@complexfive @chillapharmd that could def be the case but animal studies suggest 1) esmolol benefit likely due to increased vf threshold from b1-blockade 2) coronary perfusion (alpha agonism re: epi) associated w/  success. early b1-block➡️early ➡️early rosc https://t.co/z3vfbgmatb